300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Financial Services
Construction
Mobile
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Biotechnology
Legal
Automotive
Renewable Energy
eSports
Facebook
Blockchain
Software
Theatre
Medical
Beauty
Web3
Recruiting
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Fashion
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Infrastructure
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Social
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Paraguay
Seychelles
Botswana
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Bangladesh
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Azerbaijan
Austria
Ethiopia
Jordan
Ecuador
Bahamas
Bulgaria
Bolivia
Belize
Algeria
Belarus
Finland
Bahrain
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Jersey
Iceland
Estonia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Thomas Ebeling, Chairman of the Executive Board at ProSiebenSat.1 Media

Thomas Ebeling

Chairman of the Executive Board @ ProSiebenSat.1 Media

Boston, United States

Thomas Ebeling is a seed investor at ProSiebenSat.1 Media in Boston focused on Database and Health Care. Thomas Ebeling a standing member of OIF’s MSAB. After earning a degree in psychology in Hamburg, Thomas, began his career with Reemtsma in 1987, where he served as the product manager responsible for the “West” brand, among other duties. In 1991, he switched to Pepsi-Cola Germany, where he served as a marketing manager. In 1993, he was appointedMarketing Director for the entire beverage portfolio. Starting in 1994, he was National Sales and Franchise Director for the retail and restaurant sales of Pepsi-Cola. In 1996, he was appointed General Manager of Pepsi-Cola Germany. In 1997, he switched to Novartis, where he served as General Manager of Novartis Nutrition for Germany and Austria. In 1998, Thomas Ebeling assumed worldwide leadership of the Novartis Nutrition Division. In this position, he headed the three business units Medical Nutrition, Health Nutrition and Consumer Retail Brands, where, among other duties, he was responsible for the leading U.S. baby food brand Gerber. In 1998, he was appointed to the Novartis Executive Committee. From 2000 to October 2007, he served as CEO of the global Novartis pharmaceuticals business. Under his leadership, the company’s revenues more than doubled from US$11 billion to US$22.6 billion. In October 2007, he was appointed CEO of the Novartis Consumer Health Division. Since March 2009, he is CEO of ProSiebenSat.1 Media SE. Since 2012 Thomas Ebeling has been member of the supervisory board of Bayer AG and since 2013 he has been member of the board of directors of Lonza AG.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Thomas Ebeling invests in

DatabaseHealth CareBiotechnologyData Center AutomationInformation Technology

Stages Thomas Ebeling invests in

Seed

Countries Thomas Ebeling invests in

United States

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Database 1 (50%)
  • Health Care 1 (50%)
  • Biotechnology 1 (50%)
  • Data Center Automation 1 (50%)
  • Information Technology 1 (50%)
See all 6 industries →

Investments

CompanyDescriptionRoundLinks
ImmuneAGE Bio ImmuneAGE Bio
ImmuneAGE Bio is an intriguing initiative focused on drug discovery for immune system rejuvenation. Developing therapies that can rejuvenate or enhance the immune system could have profound implications for healthcare, especially in aging populations or those with compromised immune function $2M / Seed / Jul 11, 2024
Elicit Elicit
Elicit is an artificial intelligence research assistant that uses language models to help users automate research workflows. This research assistant finds relevant papers without a perfect keyword match, summarizes takeaways from the papers, and extracts key information from the papers. $9M / Seed / Sep 25, 2023

Co-Investors

ProSiebenSat.1 Media

About ProSiebenSat.1 Media

VC Fund · Unterföhring, Germany

ProSiebenSat.1 Media SE is a German mass media company operating television, radio stations and print businesses. The ProSiebenSat.1 Group is one of the largest independent media corporations in Europe with a reported reach of 42 million household around Europe. The company operates 15 television stations across Germany, Austria and Switzerland.ProSiebenSat.1 Media SE was established in 2000, with its headquarters in Unterföhring, Germany.

ProSiebenSat.1 Media Contacts

NameEmailPhoneSocials
Philipp Meixner
Philipp Meixner Investment Director
Thomas Ebeling
Thomas Ebeling Chairman of the Executive Board
Conrad Albert
Conrad Albert Deputy-CEO, Group General Counsel
Gerald Madlmayr
Gerald Madlmayr Performance Manager

Sign up to unlock verified contacts

Unlock Contacts

See all contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Financial Services
Construction
Mobile
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Biotechnology
Legal
Automotive
Renewable Energy
eSports
Facebook
Blockchain
Software
Theatre
Medical
Beauty
Web3
Recruiting
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Fashion
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Infrastructure
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Social
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Paraguay
Seychelles
Botswana
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Bangladesh
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Azerbaijan
Austria
Ethiopia
Jordan
Ecuador
Bahamas
Bulgaria
Bolivia
Belize
Algeria
Belarus
Finland
Bahrain
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Jersey
Iceland
Estonia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Thomas Ebeling invest in?

Thomas Ebeling invests primarily in Database, Health Care and Biotechnology startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Thomas Ebeling?

Public channels for Thomas Ebeling include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Thomas Ebeling last invest?

The most recent investment recorded for Thomas Ebeling closed in Jul 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Thomas Ebeling Thomas Ebeling Find email